Issue 3, 2025, Issue in Progress
From the journal:

RSC Advances

Correction: Genetically engineered gas vesicle proteins with proliferative potential for synergistic targeted tumor therapy

Li Lin,ab   Yan Du,a   Yaotai Wang,a   Yong Luo,ac   Fujie Jiang,a   Haiyan Yang,ad   Li Rena  and  Jianzhong Zou*a  

* Corresponding authors

a State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China
E-mail: zoujzh@cqmu.edu.cn
Tel: +86-13708302390

b Department of Ultrasound Medicine, Chongqing Shapingba Hospital, School of Medicine, Chongqing University, Chongqing, China

c Department of Ultrasound, The People's Hospital of Chongqing Liang Jiang New Area, Chongqing 400010, China

d Department of Ultrasound, Chongqing General Hospital, Chongqing University, China

Abstract

Correction for ‘Genetically engineered gas vesicle proteins with proliferative potential for synergistic targeted tumor therapy’ by Li Lin et al., RSC Adv., 2025, 15, 157–166, https://doi.org/10.1039/D4RA07532C.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D5RA90006A
Article type
Correction
Submitted
09 Jan 2025
Accepted
09 Jan 2025
First published
17 Jan 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 1576-1576

Permissions

Request permissions

Correction: Genetically engineered gas vesicle proteins with proliferative potential for synergistic targeted tumor therapy

L. Lin, Y. Du, Y. Wang, Y. Luo, F. Jiang, H. Yang, L. Ren and J. Zou, RSC Adv., 2025, 15, 1576 DOI: 10.1039/D5RA90006A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements